Central Pacific Bank - Trust Division’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$545K Buy
1,505
+215
+17% +$73.6K 0.06% 304
2026
Q1
$454K Sell
1,290
-63
-5% -$22.5K 0.06% 302
2025
Q4
$443K Buy
1,353
+857
+173% +$272K 0.05% 305
2025
Q3
$140K Hold
496
0.02% 517
2025
Q2
$138K Sell
496
-3
-0.6% -$850 0.02% 517
2025
Q1
$155K Hold
499
0.02% 492
2024
Q4
$130K Sell
499
-2,315
-82% -$687K 0.02% 530
2024
Q3
$907K Hold
2,814
0.11% 194
2024
Q2
$879K Buy
2,814
+1,350
+92% +$397K 0.1% 200
2024
Q1
$414K Buy
+1,464
New +$428K 0.05% 383

Other funds holding AMGN

Central Pacific Bank - Trust Division's AMGN Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $73.6K and bringing the position to 1,505 shares worth $545K. The position accounts for 0.06% of the portfolio, ranked #304.

Central Pacific Bank - Trust Division first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $907K in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Central Pacific Bank - Trust Division held 1,505 shares of Amgen worth $545K as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 215 Amgen shares in Q2 2026, an estimated $73.6K.
  • Amgen made up 0.06% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #304 holding.
  • Central Pacific Bank - Trust Division first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Amgen position peaked at $907K in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.